City
Epaper

Single-component Sputnik Light vaccine authorized in Egypt

By ANI | Updated: September 24, 2021 17:00 IST

The Russian Direct Investment Fund (RDIF) on Friday announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Egyptian Drug Authority (EDA).

Open in App

The Russian Direct Investment Fund (RDIF) on Friday announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Egyptian Drug Authority (EDA).

An official release stated that Sputnik Light vaccine is based on human adenovirus serotype 26 which is the first component of the Sputnik V vaccine. Immunization with Sputnik Light in Egypt will help to speed up the vaccination of the population and create herd immunity in a shorter time frame in the most populated country of the Middle East with over 100 mn people.

In February 2021, the two-dose Sputnik V vaccine was also approved in Egypt. Both Sputnik Light and Sputnik V vaccines have been approved by EDA under the emergency use authorization procedure.

Sputnik Light is safe and highly effective as demonstrated by real-world vaccination data in a number of countries. In particular, the data from the Ministry of Health of the Buenos Aires province (Argentina) shows 78.6-83.7% efficacy among the elderly. In Paraguay, Sputnik Light is 93.5% effective during the ongoing vaccination campaign according to the country's Ministry of Health.

According to the release, thanks to its safety and efficacy, the single-component Sputnik Light vaccine is now both used on a standalone basis and studied in combination with vaccines from other producers in a number of countries.

The heterogeneous boosting approach ("vaccine cocktail" using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component) was at the core of Sputnik V, the world's first registered vaccine against coronavirus.

With this approach proving successful in creating a longer and more durable immunity against the coronavirus, RDIF took the lead in initiating partnerships with other vaccine producers to conduct joint studies on the combination of the first component of Sputnik V with other vaccines.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Egyptian drug authorityEgyptBuenos AiresMinistry Of HealthMinistry of health and family affairsTurkish health ministryBaiSaudi health ministryUnion ministry of healthNew zealand ministry of healthIsraeli health ministry
Open in App

Related Stories

MumbaiDomestic Onion Prices Rise Amid Concerns Over Influx of Lower-Priced Egyptian Onions

InternationalBenjamin Netanyahu Displays Two Maps at UNGA; Palestine Absent From Both (Watch Video)

InternationalEgypt Train Collision: 3 Dead, 49 Injured in Tragic Zagazig Incident, Rescue Teams On-site

InternationalEgypt and Jordan Dispute Israel’s Allegations of Weapon Smuggling Into Gaza

InternationalGaza Humanitarian Crisis: Egypt and Iraq Emphasize Need for Immediate Resolution

International Realted Stories

InternationalJamia Hamdard hosts discussion on Nalanda's impact on modern knowledge

InternationalMuseum of the Future debuts upgraded AI-enabled humanoid robot 'Ameca'

InternationalPakistan Army Detains BSF Jawan After Accidently Crossing Border in Punjab

InternationalPahalgam terror attack: Shah and Jaishankar update President Murmu, foreign envoys briefed at MEA headquarters

InternationalGlobal condolences condemning Pahalgam terror attack continue to pour in